Medindia LOGIN REGISTER
Medindia
Advertisement

Fungus Could Treat African Sleeping Sickness

by Mohamed Fathima S on April 6, 2019 at 2:46 PM
Fungus Could Treat African Sleeping Sickness

Modern genetic engineering has turned a fungus into a disease-curing factory. According to a new study published in Proceedings of the National Academy of Sciences, the natural antibiotic is a promising cure for the neglected tropical disease human African trypanosomiasis, or African sleeping sickness, that infects thousands of people in remote and rural areas of sub-Saharan Africa every year.

"Our collaboration started about four years ago, and we have finally achieved our goal," said Professor Ikuro Abe from the University of Tokyo Department of Pharmaceutical Sciences.

Advertisement


"The gene cluster in the fungus is unique -- through a simple genetic deletion, we have engineered a strain of the fungus that only produces high concentrations of the desired antibiotic," explained Abe.

Professor Kiyoshi Kita, who retired from the University of Tokyo in 2016, dedicated a large portion of his career to understanding and curing African sleeping sickness. Abe's research team joined the project due to their expertise in mapping the chemical paths that lead from genes to proteins inside cells.
Advertisement

Abe's research team used their biosynthesis pathway expertise to genetically modify the fungus so that it produces large quantities of one specific antibiotic.

The fungus Acremonium egyptiacum naturally produces two different types of antibiotic: one is toxic to humans, but the other was identified as a potential treatment for African sleeping sickness in 1996 in part by Kita, at the time working with collaborators at the Niigata College of Pharmacy.

Artificially synthesizing the antibiotic would not be cost effective and the more common method of using bacteria to produce the chemical is infeasible.

Abe's research team identified that the fungus's two antibiotics are both made from the same precursor molecule. After the precursor is created, two separate groups of enzymes produce the two different antibiotics.

Researchers can leave the precursor molecule and the genes responsible for the desired antibiotic completely unchanged by simply deleting the genes responsible for the other toxic antibiotic.

In every liter of fungus that researchers grow in the lab, the engineered strain of the fungus can produce 500 milligrams of antibiotic.

"We think this is an exceptionally good production system," said Abe.

Researchers have applied for a patent on the engineered strain of fungus. Collaborators at the Kikkoman Corporation, best known for making soy sauce, will pursue industrial-scale growth of the genetically engineered fungus and purification of the antibiotic.

The desired antibiotic, ascofuranone, is also a candidate treatment for cancer.

About human African trypanosomiasis

People can develop African sleeping sickness by being bitten by a fly. The disease is caused by a parasite that moves from the flies, to patients' blood streams, and then into the nerves of patients' brains and spinal cords. The disease is often fatal within three years. The same parasite can also infect livestock animals.

The World Health Organization aims to eliminate human African trypanosomiasis as a public health problem by 2020.



Source: Eurekalert
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Research News

Could Light Therapy Be a Breakthrough for Alzheimer's?
Light therapy enhances sleep and psycho-behavioral symptoms in Alzheimer's patients with minimal side effects.
Does Twice Daily Stimulation Enhance Alzheimer's Mental Functions?
Electrical stimulation improves Alzheimer's patients' cognitive function and correlates with restored cortical plasticity.
South Korea's 2050 Forecast: Negative Growth Amid Low Fertility
South Korea's total fertility rate, averaging the number of children a woman aged 15-49 has in her lifetime, dropped to 0.81.
New Immunotherapy for Psoriasis & Vitiligo
Scientists identified mechanisms governing immune cells, selectively removing troublemakers to reshape skin immunity. Benefits those with psoriasis, vitiligo.
2050 Forecast: 1.06 Billion Individuals to Face 'Other' Musculoskeletal Disorders
By 2050, an anticipated increase from 494 million cases in 2020 to 1.06 billion people with musculoskeletal disabilities is expected.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Fungus Could Treat African Sleeping Sickness Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests